13 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... indicate preferred treatment ... corticosteroid; FEV1: forced ... #Management #Pulmonary
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... ICS: inhaled corticosteroids ... immunotherapy; FEV1: forced ... #GINA #Asthma #Management ... #Stepwise #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... assessment test; FEV1, forced ... #Algorithm #Management ... #Pulmonary #LABA
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Abscess Management ... Abscess Differential ... #Abscess #pulmonary ... #differential #
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
COPD, asthma, and ACO ... summary of the differential ... overlap; ICS = ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Imaging: CXR- pulmonary ... initiation • Differential ... organ dysfuxtion, ICU ... APML #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... acute coronary syndrome ... #algorithm #management ... #table #foamed ... #criticalcare #icu
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
coagulopathy) • CBC w differential ... sparing of the lung ... #differential # ... diagnosis #management ... #treatment
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
that are poorly formed ... Significance (ICUS ... factor (GCSF) treatments ... blood count with differential ... marrow studies Treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... starting amiodarone treatment ... respiratory distress syndrome ... macrophages Treatment ... #diagnosis #management